阿佩利斯制药公司
US ˙ NasdaqGS ˙ US03753U1060

介绍

本页面提供了有关 Dunlop A. Sinclair 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Dunlop A. Sinclair已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:APLS / Apellis Pharmaceuticals, Inc. Director 158,393
如何解读这些图表

以下图表显示了在Dunlop A. Sinclair进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

APLS / Apellis Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
APLS / Apellis Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 APLS / Apellis Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2024-03-19 APLS Dunlop A. Sinclair 18,681 57.1790 18,681 57.1790 1,068,161 349 24.0600 -618,695 -57.92
2023-12-01 APLS Dunlop A. Sinclair 24,000 61.1350 24,000 61.1350 1,467,240
2023-11-17 APLS Dunlop A. Sinclair 8,894 49.9910 8,894 49.9910 444,620
2023-10-17 APLS Dunlop A. Sinclair 24,000 49.0000 24,000 49.0000 1,176,000
2022-09-08 APLS Dunlop A. Sinclair 15,000 65.0000 15,000 65.0000 975,000
2022-08-11 APLS Dunlop A. Sinclair 30,000 65.6300 30,000 65.6300 1,968,900
2022-06-27 APLS Dunlop A. Sinclair 1,341 46.7881 1,341 46.7881 62,743
2022-06-23 APLS Dunlop A. Sinclair 15,000 45.0000 15,000 45.0000 675,000
2021-05-20 APLS Dunlop A. Sinclair 5,773 48.1000 5,773 48.1000 277,681
2021-05-19 APLS Dunlop A. Sinclair 7,612 50.0000 7,612 50.0000 380,600
2021-05-18 APLS Dunlop A. Sinclair 64,179 51.6600 64,179 51.6600 3,315,487
2021-05-18 APLS Dunlop A. Sinclair 14,216 52.6300 14,216 52.6300 748,188
2021-05-18 APLS Dunlop A. Sinclair 36,387 53.7800 36,387 53.7800 1,956,893
2021-05-18 APLS Dunlop A. Sinclair 22,318 54.5700 22,318 54.5700 1,217,893
2021-05-18 APLS Dunlop A. Sinclair 1,200 52.0100 1,200 52.0100 62,412
2021-05-18 APLS Dunlop A. Sinclair 10,388 53.5000 10,388 53.5000 555,758
2021-05-18 APLS Dunlop A. Sinclair 800 54.0200 800 54.0200 43,216
2020-12-14 APLS Dunlop A. Sinclair 7,654 53.8600 7,654 53.8600 412,244
2020-12-14 APLS Dunlop A. Sinclair 17,132 55.0100 17,132 55.0100 942,431
2020-12-14 APLS Dunlop A. Sinclair 214 56.2500 214 56.2500 12,038
2020-12-07 APLS Dunlop A. Sinclair 9,094 50.4100 9,094 50.4100 458,429
2020-12-07 APLS Dunlop A. Sinclair 9,470 51.0000 9,470 51.0000 482,970
2020-12-04 APLS Dunlop A. Sinclair 5,052 50.0400 5,052 50.0400 252,802
2020-12-04 APLS Dunlop A. Sinclair 1,384 51.0500 1,384 51.0500 70,653
2019-12-20 APLS Dunlop A. Sinclair 25,000 29.5300 25,000 29.5300 738,250
2019-12-19 APLS Dunlop A. Sinclair 54,110 28.9900 54,110 28.9900 1,568,649
2019-12-19 APLS Dunlop A. Sinclair 31,000 29.5100 31,000 29.5100 914,810
2019-12-18 APLS Dunlop A. Sinclair 25,890 28.5500 25,890 28.5500 739,160

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

APLS / Apellis Pharmaceuticals, Inc. Insider Trades
内幕交易历史

该表格显示了由 Dunlop A. Sinclair 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2025-01-03 2025-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 6,267 158,393 4.12
2024-09-24 2024-09-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 4,600 152,126 3.12 13.19 60,674 2,006,542
2024-09-17 2024-09-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -7,524 100,000 -7.00 36.79 -276,808 3,679,000
2024-09-17 2024-09-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -29,476 107,524 -21.52 36.09 -1,063,789 3,880,541
2024-07-01 2024-06-28 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 900 134,418 0.67 13.19 11,871 1,772,973
2024-06-21 2024-06-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,695 136,998 -1.22 39.63 -67,173 5,429,231
2024-06-21 2024-06-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -35,305 138,693 -20.29 39.22 -1,384,662 5,439,539
2024-04-15 2024-04-12 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 1,500 133,518 1.14 13.19 19,785 1,761,102
2024-03-20 2024-03-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -18,681 173,998 -9.70 57.18 -1,068,161 9,949,032
2024-01-02 2024-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 3,341 132,018 2.60
2023-12-15 2023-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 6,274 128,677 5.13 13.19 82,754 1,697,250
2023-12-05 2023-12-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -24,000 192,679 -11.08 61.14 -1,467,240 11,779,431
2023-11-21 2023-11-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -8,894 122,403 -6.77 49.99 -444,620 6,119,048
2023-11-21 2023-10-17 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -24,000 216,679 -9.97 49.00 -1,176,000 10,617,271
2023-04-05 2023-04-03 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 131,297 -0.38 74.05 -37,025 9,722,543
2023-03-02 2023-03-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 131,797 -0.38 65.33 -32,665 8,610,298
2023-02-02 2023-02-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 132,297 -0.38 52.61 -26,305 6,960,145
2023-01-05 2023-01-03 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 132,797 -0.38 50.70 -25,350 6,732,808
2023-01-04 2023-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 3,867 133,297 2.99
2022-12-02 2022-12-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 129,430 -0.38 49.93 -24,965 6,462,440
2022-11-03 2022-11-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 129,930 -0.38 60.83 -30,415 7,903,642
2022-09-08 2022-09-08 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -15,000 240,679 -5.87 65.00 -975,000 15,644,135
2022-08-26 2022-08-25 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 4,306 130,430 3.41 13.19 56,796 1,720,372
2022-08-17 2022-08-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 25,394 126,124 25.21 14.00 355,516 1,765,736
2022-08-12 2022-08-11 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -30,000 255,679 -10.50 65.63 -1,968,900 16,780,213
2022-07-22 2022-07-21 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 9,606 100,730 10.54 14.00 134,484 1,410,220
2022-06-29 2022-06-27 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,341 1,341 -50.00 46.79 -62,743 62,743
2022-06-24 2022-06-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -15,000 285,679 -4.99 45.00 -675,000 12,855,555
2022-04-25 2022-04-22 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -20,000 35,000 -36.36
2022-04-25 2022-04-22 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 20,000 91,124 28.12 14.00 280,000 1,275,736
2022-01-04 2022-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 8,554 8,554
2022-01-04 2022-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		A - Award 4,230 71,124 6.32
2021-09-13 2021-09-10 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -6,894 55,000 -11.14
2021-09-13 2021-09-10 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 6,894 66,894 11.49 14.00 96,516 936,516
2021-06-02 2021-06-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		J - Other 2,682 303,361 0.89
2021-06-02 2021-06-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		J - Other 13,108 73,108 21.85
2021-06-02 2021-06-01 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		J - Other -31,855 0 -100.00
2021-05-20 2021-05-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,773 31,855 -15.34 48.10 -277,681 1,532,226
2021-05-20 2021-05-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -7,612 300,679 -2.47 50.00 -380,600 15,033,950
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -800 308,291 -0.26 54.02 -43,216 16,653,880
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,388 309,091 -3.25 53.50 -555,758 16,536,368
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,200 319,479 -0.37 52.01 -62,412 16,616,103
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -22,318 37,628 -37.23 54.57 -1,217,893 2,053,360
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -36,387 59,946 -37.77 53.78 -1,956,893 3,223,896
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -14,216 96,333 -12.86 52.63 -748,188 5,070,006
2021-05-20 2021-05-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -64,179 110,549 -36.73 51.66 -3,315,487 5,710,961
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -10,000 61,894 -13.91
2021-04-26 2021-04-23 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 10,000 60,000 20.00 14.00 140,000 840,000
2021-04-19 2021-04-16 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		M - Exercise -50,000 71,894 -41.02
2021-04-19 2021-04-16 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		M - Exercise 50,000 50,000 14.00 700,000 700,000
2021-01-04 2021-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 27,600 27,600
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -214 174,728 -0.12 56.25 -12,038 9,828,450
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -17,132 174,942 -8.92 55.01 -942,431 9,623,559
2020-12-15 2020-12-14 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -7,654 192,074 -3.83 53.86 -412,244 10,345,106
2020-12-07 2020-12-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -9,470 199,728 -4.53 51.00 -482,970 10,186,128
2020-12-07 2020-12-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -9,094 209,198 -4.17 50.41 -458,429 10,545,671
2020-12-07 2020-12-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,384 218,292 -0.63 51.05 -70,653 11,143,807
2020-12-07 2020-12-04 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,052 219,676 -2.25 50.04 -252,802 10,992,587
2020-01-03 2020-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Stock Option (Right to Buy) 		A - Award 27,600 27,600 30.62 845,112 845,112
2019-12-20 2019-12-20 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -25,000 224,728 -10.01 29.53 -738,250 6,636,218
2019-12-20 2019-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -31,000 249,728 -11.04 29.51 -914,810 7,369,473
2019-12-20 2019-12-19 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -54,110 320,681 -14.44 28.99 -1,568,649 9,296,542
2019-12-20 2019-12-18 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		S - Sale -25,890 374,791 -6.46 28.55 -739,160 10,700,283
2019-01-03 2019-01-01 4 APLS Apellis Pharmaceuticals, Inc.
Stock option (right to buy) 		A - Award 17,580 17,580
2018-05-09 2018-05-07 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		J - Other 94,357 280,728 50.63
2017-11-13 2017-11-13 4 APLS Apellis Pharmaceuticals, Inc.
Series E Preferred Stock 		C - Conversion -6,078 0 -100.00
2017-11-13 2017-11-13 4 APLS Apellis Pharmaceuticals, Inc.
Series D Preferred Stock 		C - Conversion -31,478 0 -100.00
2017-11-13 2017-11-13 4 APLS Apellis Pharmaceuticals, Inc.
Series C Preferred Stock 		C - Conversion -150,023 0 -100.00
2017-11-13 2017-11-13 4 APLS Apellis Pharmaceuticals, Inc.
Series B Preferred Stock 		C - Conversion -213,100 0 -100.00
2017-11-13 2017-11-13 4 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		C - Conversion 400,679 400,679
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		372,742
2017-11-08 3 APLS Apellis Pharmaceuticals, Inc.
Common Stock 		372,742
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）